Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal) is Pharmaceuticals in India that focus on fungal infections business. They cover business area such as developer, gynecological drug, India, medicine, menstrual disorder, a deficiency, hormone, anaemia, abnormal heavy bleeding, menstrual period, pregnancy, kidney problem, fungal infection.
-
Fungal Infections
-
Mumbai, Maharashtra
India
Private
developergynecological drugIndiamedicinemenstrual disordera deficiencyhormoneanaemiaabnormal heavy bleedingmenstrual periodpregnancykidney problemfungal infection
* We use standard office opening hours in near Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Glenmark Pharmaceuticals (Gynaecology Business In India And Nepal) is Pharmaceuticals business from India that founded in - ( years old in ), Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal) business is focusing on Fungal Infections.
Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal) headquarter office and corporate office address is located in Mumbai, Maharashtra India.
Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal) was founded in India.
In , Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal) is currently focus on fungal infections sector.
Above is snippet of Google Trends for "fungal infections" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Glenmark Pharmaceuticals (Gynaecology Business in India and Nepal), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.